That is to say, BBR represses Wnt/β-catenin pathway activation via modulating the miR-103a-3p/BRD4 axis, thereby refraining pyroptosis and reducing the intestinal mucosal barrier defect induced via colitis. This evidence concerns the gene BRD4 and colitis.